NCT00601900
Clinical Trial Information
Trial Number: NCT00601900 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
Endocrine Therapy With or Without Anti-VEGF Therapy: A Randomized, Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC 704865) for Women With Hormone Receptor-Positive Advanced Breast Cancer
Study ID:
CALGB-40503
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00601900-D2 | NCT00601900-D2 (AE) data set allows you to reproduce the reported adverse events for this study. |
| NCT00601900-D1 | NCT00601900-D1 (efficacy) contains one observation per patient enrolled in Phase III Letrozole trial (N=350). The data contained allows you to reproduce the efficacy data on the N=343 randomized and treated patients (use code treated=1 to identify). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®